EP2310385 - Bibliographic data

COMPOSITION PHARMACEUTIQUE SOLIDE

Last update 17/06/2025
Legal status Brevet déchu
Origin Euro-PCT
(73) Holder

Takeda Pharmaceutical Company Limited

1-1 Doshomachi 4-chome Chuo-ku
Osaka-shi, Osaka 541-0045
Japon
(72) Inventors

Yutaka TANOUE

c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED 17-85 Jusohonmachi 2-chome Yodogawa-ku
Osaka-shi Osaka 532-8686
Japon

Junya NOMURA

c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED 17-85 Jusohonmachi 2-chome Yodogawa-ku
Osaka-shi Osaka 532-8686
Japon
(74) Agent

Mail recipient

Dossmann, Gérard

Casalonga & Partners Bayerstrasse 71-73
80335 München
Allemagne
(21) Request number EP09788017.3
(22) Request date 29/07/2009
(11) Publication number EP2310385
Publication date 07/06/2017
(54) Title of the invention COMPOSITION PHARMACEUTIQUE SOLIDE
(51) International classification C07D 413/14, A61P 9/12, A61K 31/4245
International classification (before reform) None
Claimed priority

(31) Number: 85201 P
(32) Date: 31/07/2008
(33) Country: US

Initial application None
Divisional application None
Expected annuity Annuity: 9 - Amount: 145 € - Due date 07/08/2017
Surtax: 9 - Amount: 29 € - Due date 08/02/2018
Last annuity None
Publication None
History

Publication de la délivrance du brevet européen - Legal date 07/06/2017

Entrée en période de grâce du brevet d'invention - Legal date 08/08/2017

Déchéance du brevet d'invention après période de grâce - Legal date 07/08/2017